Pittsburgh

FDA gives emergency use authorization for Regeneron COVID-19 treatment – Pittsburgh, Pennsylvania

Pittsburgh, Pennsylvania 2020-11-21 20:28:00 –

The Food and Drug Administration announced on Saturday that it has granted Regeneron Pharmaceuticals an emergency license to treat COVID-19 in certain individuals. Mild and moderate COVID in high-risk adult and pediatric patients 12 years and older- Approved to treat 19 treatments, including FDA Casilibimab and Imdebimab, have been shown to reduce hospitalizations or visits to emergency rooms for high-risk patients. “Approving these monoclonal antibody therapies may help outpatients avoid hospitalization and reduce the burden on our healthcare system,” Hahn said in a statement. Monoclonal antibodies (laboratory proteins) help the immune system fight pathogens. President Donald Trump celebrated the administration of the experimental monoclonal antibody given to help him deal with the COVID-19 case. Helped him defeat his coronavirus infection at record speed. CNN has contributed.

The Food and Drug Administration said on Saturday that it had granted Regeneron Pharmaceuticals an emergency license to treat COVID-19 in certain individuals.

The FDA has approved the treatment of mild and moderate COVID-19 in high-risk adults and pediatric patients aged 12 years and older.

Treatments containing Casilibimab and Imdebimab have been shown to reduce hospitalizations or visits to the emergency room for high-risk patients.

“Approving these monoclonal antibody therapies may help outpatients avoid hospitalization and reduce the burden on our healthcare system,” FDA Commissioner Dr. Stephen Hahn said in a statement. I did.

Monoclonal antibodies (proteins made in the laboratory) help the immune system fight pathogens.

President Donald Trump celebrated the administration of the experimental monoclonal antibody given to address the case of COVID-19. He said he thinks it helped to defeat his coronavirus infection in record time.

CNN contributed.

FDA gives emergency use authorization for Regeneron COVID-19 treatment Source link FDA gives emergency use authorization for Regeneron COVID-19 treatment

Back to top button